OpGen Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Public

  • Employees
  • 100

Employees

  • Stock Symbol
  • OPGN

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $1.38
  • (As of Friday Closing)

OpGen General Information

Description

OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.

Contact Information

Website
www.opgen.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 9717 Key West Avenue
  • Suite 100
  • Rockville, MD 20850
  • United States
+1 (301)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Healthcare Technology Systems
Stock Exchange
PINX
Vertical(s)
Corporate Office
  • 9717 Key West Avenue
  • Suite 100
  • Rockville, MD 20850
  • United States
+1 (301)

OpGen Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OpGen Stock Performance

As of 14-Feb-2025, OpGen’s stock price is $1.38. Its current market cap is $13.9M with 10.1M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.38 $1.38 $0.53 - $9.90 $13.9M 10.1M 5.6K -$15.16

OpGen Financials Summary

As of 30-Sep-2024, OpGen has a trailing 12-month revenue of $1.27M.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 29,934 16,466 12,733 38,391
Revenue 1,266 3,418 2,607 4,306
EBITDA (9,176) (29,653) (32,431) (27,294)
Net Income (9,399) (32,669) (37,283) (34,806)
Total Assets 5,470 1,882 25,813 71,667
Total Debt 2,241 13,044 14,822 25,179
Public Fundamental Data provided by Morningstar, Inc. disclaimer

OpGen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OpGen‘s full profile, request access.

Request a free trial

OpGen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore OpGen‘s full profile, request access.

Request a free trial

OpGen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat i
Biotechnology
Rockville, MD
100 As of 2022

Oklahoma City, OK
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OpGen Competitors (39)

One of OpGen’s 39 competitors is Progentec, a Venture Capital-Backed company based in Oklahoma City, OK.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Progentec Venture Capital-Backed Oklahoma City, OK
Superfluid DX Venture Capital-Backed South San Francisco, CA
Strata Oncology Venture Capital-Backed Ann Arbor, MI
AnTolRx Venture Capital-Backed Cambridge, MA
DNAnexus Venture Capital-Backed Mountain View, CA
You’re viewing 5 of 39 competitors. Get the full list »

OpGen Patents

OpGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170253917-A1 Methods and systems for determining antibiotic susceptibility Inactive 07-Mar-2016
CA-3016632-A1 Methods and systems for determining antibiotic susceptibility Inactive 07-Mar-2016
EP-3426800-A1 Methods and systems for determining antibiotic susceptibility Inactive 07-Mar-2016
US-20160053219-A1 Systems, methods, and devices for temperature control Inactive 25-Aug-2014
CA-2950327-A1 Systems, apparatus, and methods for generating and analyzing resistome profiles Inactive 27-May-2014 G16H50/80
To view OpGen’s complete patent history, request access »

OpGen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OpGen Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OpGen‘s full profile, request access.

Request a free trial

OpGen Acquisitions (2)

OpGen’s most recent deal was a Merger/Acquisition with Curetis. The deal was made on 01-Apr-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Curetis 01-Apr-2020 Merger/Acquisition Diagnostic Equipment
AdvanDx 14-Jul-2015 Merger/Acquisition Diagnostic Equipment
To view OpGen’s complete acquisitions history, request access »

OpGen Exits (1)

OpGen’s most recent exit was on 01-Apr-2020 from Curetis. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Curetis 01-Apr-2020 Completed
To view OpGen’s complete exits history, request access »

OpGen FAQs

  • When was OpGen founded?

    OpGen was founded in 2001.

  • Where is OpGen headquartered?

    OpGen is headquartered in Rockville, MD.

  • What is the size of OpGen?

    OpGen has 100 total employees.

  • What industry is OpGen in?

    OpGen’s primary industry is Biotechnology.

  • Is OpGen a private or public company?

    OpGen is a Public company.

  • What is OpGen’s stock symbol?

    The ticker symbol for OpGen is OPGN.

  • What is the current stock price of OpGen?

    As of 14-Feb-2025 the stock price of OpGen is $1.38.

  • What is the current market cap of OpGen?

    The current market capitalization of OpGen is $13.9M.

  • What is OpGen’s current revenue?

    The trailing twelve month revenue for OpGen is $1.27M.

  • Who are OpGen’s competitors?

    Progentec, Superfluid DX, Strata Oncology, AnTolRx, and DNAnexus are some of the 39 competitors of OpGen.

  • What is OpGen’s annual earnings per share (EPS)?

    OpGen’s EPS for 12 months was -$15.16.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »